Back
Movado Group Vs. Janux Therapeutics Industry Stock Comparison
Buy
54
MOV
Movado Group
Last Price:
26.98
Seasonality Move:
6.23%
Sell
43
JANX
Janux Therapeutics
Last Price:
45.45
Seasonality Move:
8.69%
Buy
54
Movado Group (MOV)
is a Buy
Is Movado Group a Buy, Sell or Hold?
- The current Movado Group [MOV] share price is $27.03. The Score for MOV is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- MOV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $47.99. The Score for JANX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MOV Stock Price Chart
What is Movado Group's stock price today?
-
The Movado Group share price today is $27.03
The current trend is moderately bullish and MOV is experiencing selling pressure, which indicates risk of future bearish movement.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $47.99
The current trend is moderately bearish and JANX is experiencing slight selling pressure.
MOV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 55.77 | Buy |
| Chaikin Money Flow: | -90859 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.46 - 26.94) | Buy |
| Bollinger Bands (100): | (26.23 - 28.81) | Sell |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 46.13 | Sell |
| Chaikin Money Flow: | -166576 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.56 - 57.74) | Sell |
| Bollinger Bands (100): | (12.73 - 49.75) | Buy |
MOV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.01 | Buy |
| 20-day SMA: | 26.44 | Buy |
| 50-day SMA: | 26.53 | Buy |
| 200-day SMA: | 27.74 | Sell |
| 8-day EMA: | 27.01 | Buy |
| 20-day EMA: | 26.64 | Buy |
| 50-day EMA: | 26.75 | Buy |
| 200-day EMA: | 27.76 | Sell |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.61 | Sell |
| 20-day SMA: | 52.95 | Sell |
| 50-day SMA: | 46.13 | Buy |
| 200-day SMA: | 20.35 | Buy |
| 8-day EMA: | 49.4 | Sell |
| 20-day EMA: | 50.62 | Sell |
| 50-day EMA: | 45.17 | Buy |
| 200-day EMA: | 26.75 | Buy |
Movado Group Earnings Growth & MOV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.78 per share, and an increase next year of $1.52 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.05 per share, an increase this year of $0.09 per share, and a decrease next year of $0.57 per share.
Movado Group Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||